These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26228679)

  • 1. Statin desensitization in a patient with probable familial hypercholesterolemia.
    Schultz AE; Snider MJ; Blais DM; Gulati M
    J Clin Lipidol; 2015; 9(4):597-601. PubMed ID: 26228679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful reintroduction of statin therapy after statin-associated rhabdomyolysis.
    Simons JE; Holbrook AM; Don-Wauchope AC
    J Clin Lipidol; 2015; 9(4):594-6. PubMed ID: 26228678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid intima-media thickness in children with familial hypercholesterolemia.
    Kusters DM; Wiegman A; Kastelein JJ; Hutten BA
    Circ Res; 2014 Jan; 114(2):307-10. PubMed ID: 24192652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
    Khine H; Yuet WC; Adams-Huet B; Ahmad Z
    Am Heart J; 2016 Sep; 179():1-9. PubMed ID: 27595674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target achievement with maximal statin-based lipid-lowering therapy in Korean patients with familial hypercholesterolemia: A study supported by the Korean Society of Lipid and Atherosclerosis.
    Oh J; Lee CJ; Kim DI; Rhee MY; Lee BK; Ahn Y; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee SH
    Clin Cardiol; 2017 Dec; 40(12):1291-1296. PubMed ID: 29243274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].
    Bea AM; Mateo-Gallego R; Jarauta E; Villa-Pobo R; Calmarza P; Lamiquiz-Moneo I; Cenarro A; Civeira F
    Clin Investig Arterioscler; 2014; 26(4):176-83. PubMed ID: 24576773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
    Luirink IK; Wiegman A; Kusters DM; Hof MH; Groothoff JW; de Groot E; Kastelein JJP; Hutten BA
    N Engl J Med; 2019 Oct; 381(16):1547-1556. PubMed ID: 31618540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.
    Avis HJ; Hutten BA; Gagné C; Langslet G; McCrindle BW; Wiegman A; Hsia J; Kastelein JJ; Stein EA
    J Am Coll Cardiol; 2010 Mar; 55(11):1121-6. PubMed ID: 20223367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
    Pérez de Isla L; Arroyo-Olivares R; Muñiz-Grijalvo O; Diaz-Díaz JL; Zambón D; Fuentes F; Sánchez Muñoz-Torrero JF; Mediavilla JD; González-Estrada A; Miramontes-González JP; de Andrés R; Mauri M; Mosquera D; Cepeda JM; Suárez L; Barba-Romero MÁ; Argüeso R; Álvarez-Baños P; Michán A; Romero-Jiménez MJ; García-Cruces J; Padró T; Alonso R; Mata P
    J Clin Lipidol; 2019; 13(6):989-996. PubMed ID: 31706904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Atherosclerosis; 2015 Aug; 241(2):450-4. PubMed ID: 26074319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.
    Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagné C; Gaudet D; Morrison KM; Wiegman A; Turner T; Kusters DM; Miller E; Raichlen JS; Wissmar J; Martin PD; Stein EA; Kastelein JJP
    J Clin Lipidol; 2015; 9(6):741-750. PubMed ID: 26687694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
    Stein EA; Amerena J; Ballantyne CM; Brice E; Farnier M; Guthrie RM; Harats D; Ma PT; Le Maulf F; Melezínková H; Gold A; Sager P
    Am J Cardiol; 2007 Nov; 100(9):1387-96. PubMed ID: 17950795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial.
    Koeijvoets KC; Rodenburg J; Hutten BA; Wiegman A; Kastelein JJ; Sijbrands EJ
    Circulation; 2005 Nov; 112(20):3168-73. PubMed ID: 16286607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin in the management of hyperlipidemia.
    Cheng JW
    Clin Ther; 2004 Sep; 26(9):1368-87. PubMed ID: 15531000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention.
    Rollefstad S; Ikdahl E; Hisdal J; Kvien TK; Pedersen TR; Holme I; Semb AG
    Ann Rheum Dis; 2015 Aug; 74(8):1544-50. PubMed ID: 24699940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.
    van Tits LJ; van Himbergen TM; Lemmers HL; de Graaf J; Stalenhoef AF
    Atherosclerosis; 2006 Apr; 185(2):307-12. PubMed ID: 16005883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.
    Hovingh GK; Smits LP; Stefanutti C; Soran H; Kwok S; de Graaf J; Gaudet D; Keyserling CH; Klepp H; Frick J; Paolini JF; Dasseux JL; Kastelein JJ; Stroes ES
    Am Heart J; 2015 May; 169(5):736-742.e1. PubMed ID: 25965722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.